Treatment of type 2 diabetes mellitus in elderly patients

被引：28

作者：

Gomez-Huelgas, R. ^{[1
,2
,3
,4
]}

Gomez Peralta, F. ^{[5
,6
]}

Rodriguez Manas, L. ^{[7
,8
,9
]}

Formiga, F. ^{[10
,11
]}

Puig Domingo, M. ^{[12
,13
,14
,15
]}

Mediavilla Bravo, J. J. ^{[16
,17
]}

Miranda, C. ^{[18
,19
]}

Ena, J. ^{[4
,20
]}

机构：

[1] Univ Malaga, Hosp Reg, Serv Med Interna, Malaga, Spain

[2] Inst Invest Biomed Malaga IBIMA, Malaga, Spain

[3] Inst Salud Carlos III, CIBER Obesidad & Nutr CIBEROBN, Madrid, Spain

[4] SEMI, Madrid, Spain

[5] Hosp Gen Segovia, Unidad Endocrinol & Nutr, Segovia, Spain

[6] SED, Madrid, Spain

[7] Hosp Univ Getafe, Serv Geriatria, Madrid, Spain

[8] Inst Salud Carlos III, CIBER Fragilidad & Envejecimiento Saludable CIBER, Madrid, Spain

[9] Soc Espanola Med Geriatr SEMEG, Madrid, Spain

[10] Hosp Univ Bellvitge, Unidad Geriatria, Barcelona, Spain

[11] SEGG, Madrid, Spain

[12] Hosp Badalona Germans Trias & Pujol, Serv Endocrinol & Nutr, Barcelona, Spain

[13] Inst Invest Ciencies Salut Germans Trias & Pujol, Barcelona, Spain

[14] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain

[15] SEEN, Madrid, Spain

[16] Ctr Salud Burgos Rural, Burgos, Spain

[17] Soc Espanola Med Gen SEMERGEN, Madrid, Spain

[18] Ctr Salud Buenavista, Toledo, Spain

[19] Soc Espanola Med Gen &Familia SEMG, Madrid, Spain

[20] Hosp Marina Baixa, Serv Med Interna, Alicante, Spain

来源：

REVISTA CLINICA ESPANOLA | 2018年 / 218卷 / 02期

关键词：

Type 2 diabetes mellitus; Elderly; Antidiabetic treatment; RANDOMIZED CLINICAL-TRIAL; BIPHASIC INSULIN ASPART; ONCE-WEEKLY DULAGLUTIDE; CHRONIC KIDNEY-DISEASE; FRAIL OLDER-ADULTS; DOUBLE-BLIND; GLYCEMIC CONTROL; CARDIOVASCULAR OUTCOMES; POOLED ANALYSIS; OPEN-LABEL;

D O I：

10.1016/j.rce.2017.12.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The prevalence of type 2 diabetes mellitus (DM2) increases markedly with age. Anti diabetic treatment and the objectives of glycaemic control in elderly patients with DM2 should be individualised according to their biopsychosocial characteristics. In elderly patients for whom the benefits of intensive antidiabetic treatment are limited, the basic objectives should be to improve the quality of life, preserve functionality and avoid adverse effects, especially hypoglycaemia. Treatment of DM2 in the elderly was the subject of a consensus document published in 2012 and endorsed by several Spanish scientific societies. Since then, new therapeutic groups and evidence have emerged that warrant an update to this consensus document. The present document focuses on the therapeutic aspects of DM2 in elderly patients, understood as being older than 75 years or frail. (C) 2017 Elsevier Espana, S.L.U. and Sociedad Espanola de Medicina Interna (SEMI). All rights reserved.

引用

页码：74 / 88

页数：15

共 50 条

[41] Diagnosis and treatment of early renal disease in patients with type 2 diabetes mellitus: what are the clinical needs?
Mann, Johannes F. E.
Rossing, Peter
Wiecek, Andrzej
Rosivall, Laszlo
Mark, Patrick
Mayer, Gert
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : 1 - 5
[42] Barriers to insulin treatment in patients with type 2 diabetes mellitus
Tziomalos, Konstantinos
EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (03) : 233 - 234
[43] TREATMENT OF HYPOGONADISM WITH TESTOSTERONE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Gopal, Raju A.
Bothra, Nikita
Acharya, Shrikrishna V.
Ganesh, Hosahithlu K.
Bandgar, Tushar R.
Menon, Padma S.
Shah, Nalini S.
ENDOCRINE PRACTICE, 2010, 16 (04) : 570 - 576
[44] Medical treatment of type 2 diabetes mellitus: Recommendations of the Diabetes, Obesity and Nutrition Group of the Spanish Society of Internal Medicine
Carrasco-Sanchez, F. J.
Fernandez-Rodriguez, J. M.
Ena, J.
Gomez-Huelgas, R.
Carretero-Gomez, J.
REVISTA CLINICA ESPANOLA, 2021, 221 (02): : 101 - 108
[45] Depression in elderly patients with type 2 diabetes
Petrak, F.
Plack, K.
DIABETOLOGE, 2010, 6 (07): : 541 - +
[46] Dapagliflozin for the treatment of type 2 diabetes mellitus - an update
Nicholson, Martha K.
Ghazal Asswad, Randa
Wilding, John P. H.
EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (17) : 2303 - 2310
[47] Canagliflozin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus
Plosker, Greg L.
DRUGS, 2014, 74 (07) : 807 - 824
[48] Weighing Coronary Revascularization Options in Patients With Type 2 Diabetes Mellitus
Godoy, Lucas C.
Tavares, Caio A. M.
Farkouh, Michael E.
CANADIAN JOURNAL OF DIABETES, 2020, 44 (01) : 78 - 85
[49] Evaluating gliclazide for the treatment of type 2 diabetes mellitus
Tomlinson, Brian
Li, Yan-Hong
Chan, Paul
EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (17) : 1869 - 1877
[50] EVALUATION OF SERUM OSTEOCALCIN IN ELDERLY PATIENTS WITH TYPE-2 DIABETES MELLITUS
Gradinaru, Daniela
Mitrea, Niculina
Margina, Denisa
Arsene, Andreea L.
Gruia, Vlad
Dragoi, Cristina
Nicolae, Alina
Borsa, Claudia
Gherasim, Petre
FARMACIA, 2009, 57 (03) : 331 - 338

← 1 2 3 4 5 →